Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dren Bio
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Hangzhou Hanx Biopharmaceuticals, Ltd.
University of Pittsburgh
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Genentech, Inc.
Boehringer Ingelheim
Ohio State University Comprehensive Cancer Center
The Netherlands Cancer Institute
Canadian Cancer Trials Group
Yale University
Thomas Jefferson University
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Incyte Corporation
Diakonos Oncology Corporation
Merck Sharp & Dohme LLC
Mayo Clinic
Immatics US, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
Toray Industries, Inc
National Cancer Institute (NCI)
Providence Health & Services
Johns Hopkins University
University of Pittsburgh
7 Hills Pharma, LLC
Immatics US, Inc.
Istituto Oncologico Veneto IRCCS
Merck Sharp & Dohme LLC
University of Pittsburgh
University of Alabama at Birmingham
Regeneron Pharmaceuticals
KaliVir Immunotherapeutics
National Institutes of Health Clinical Center (CC)
Alpha Tau Medical LTD.
Eastern Cooperative Oncology Group
Iovance Biotherapeutics, Inc.
Soligenix
NRG Oncology
University of Thessaly
M.D. Anderson Cancer Center
Replimune Inc.
National Institutes of Health Clinical Center (CC)